Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-0.0%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 60.71% |
| 2024 | 86.21% |
| 2023 | 53.12% |
| 2022 | 60.74% |
| 2021 | -82.31% |
| 2020 | -50.50% |
| 2019 | 46.68% |
| 2018 | -8.02% |
| 2017 | -109.61% |
| 2016 | -47.35% |